Zimmer Biomet (ZBH) PT Raised to $160 at SVB Leerink After Management NDR
Tweet Send to a Friend
SVB Leerink analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $160.00 (from $153.00) after hosting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
